Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer

The early detection of ovarian carcinoma is difficult due to the absence of recognizable physical symptoms and a lack of sensitive screening methods. The currently available biomarkers (such as CA125 and HE4) are insufficiently reliable to distinguish early stage (I/II) epithelial ovarian cancer (EO...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Lijun, Yin, Mingzhu, Ke, Chaofu, Ge, Tingting, Zhang, Guangming, Zhang, Wang, Zhou, Xiaohua, Lou, Ge, Li, Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934035/
https://www.ncbi.nlm.nih.gov/pubmed/27390602
http://dx.doi.org/10.7150/jca.15074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934035/
https://www.ncbi.nlm.nih.gov/pubmed/27390602
http://dx.doi.org/10.7150/jca.15074

Ejemplares similares